Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Opus Genetics
company
About
Opus Genetics is a gene therapy company for ultra-rare blinding conditions.
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $19M
- Industries
- Health Care,Health Diagnostics,Wellness
- Founded date
- Jan 1, 2004
- Operating Status
- Active
Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$19M
Opus Genetics has raised a total of
$19M
in funding over 2 rounds. Their latest funding was raised on
Sep 22, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 22, 2021 | Seed | $19M | 1 |
Retinal Degeneration Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Opus Genetics is funded by 1 investors.
Retinal Degeneration Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Retinal Degeneration Fund
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
